(-0.04%) 5 211.50 points
(0.02%) 39 034 points
(-0.08%) 18 184 points
(-1.15%) $77.48
(1.59%) $2.24
(-0.17%) $2 320.30
(-0.50%) $27.41
(-1.20%) $976.50
(0.05%) $0.930
(0.19%) $10.92
(0.14%) $0.801
(0.24%) $91.66
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 6.79%
2.95% $ 10.48
@ $8.22
Emitido: 14 feb 2024 @ 09:30
Retorno: 27.49%
Señal anterior: feb 13 - 09:30
Señal anterior:
Retorno: -2.26 %
Live Chart Being Loaded With Signals
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients...
Stats | |
---|---|
Volumen de hoy | 742 058 |
Volumen promedio | 815 685 |
Capitalización de mercado | 545.04M |
EPS | $0 ( 2024-02-28 ) |
Próxima fecha de ganancias | ( $-0.190 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.96 |
ATR14 | $0.0190 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Novack Jeffrey Adam | Sell | 1 905 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 0 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 385 | Employee Stock Option (right to buy) |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 150 | Employee Stock Option (right to buy) |
2024-05-01 | Jain Abhishek | Sell | 7 371 | Common Stock |
INSIDER POWER |
---|
8.63 |
Last 100 transactions |
Buy: 1 531 623 | Sell: 918 597 |
Volumen Correlación
CareDx Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
INFI | 0.962 |
BAND | 0.958 |
NKTR | 0.955 |
FULC | 0.954 |
INGN | 0.953 |
ORGS | 0.953 |
UPLD | 0.949 |
JAGX | 0.941 |
MICS | 0.936 |
GOODM | 0.934 |
10 Correlaciones Más Negativas | |
---|---|
TIG | -0.918 |
TYHT | -0.915 |
MYRG | -0.913 |
SGEN | -0.911 |
OPCH | -0.906 |
PPYAU | -0.898 |
APEN | -0.889 |
RELY | -0.889 |
KNBE | -0.882 |
ALTR | -0.88 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CareDx Inc Correlación - Moneda/Commodity
CareDx Inc Finanzas
Annual | 2023 |
Ingresos: | $280.32M |
Beneficio Bruto: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2023 |
Ingresos: | $280.32M |
Beneficio Bruto: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2022 |
Ingresos: | $321.79M |
Beneficio Bruto: | $209.58M (65.13 %) |
EPS: | $-1.440 |
FY | 2021 |
Ingresos: | $296.40M |
Beneficio Bruto: | $199.01M (67.14 %) |
EPS: | $-0.582 |
Financial Reports:
No articles found.
CareDx Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico